The association of neighborhood-level deprivation with glioblastoma outcomes: a single center cohort study
Journal of Neuro-Oncology · 2025
DOI: 10.1007/s11060-025-05002-3 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Neuro-Oncology, 2025. Verfasst von Yifei Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Marnix E. Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Residence Characteristics, Neighborhood Characteristics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Neurological Disorders and Stroke of the National Institutes of Health.
Abstract (Originalsprache)
Glioblastoma is the most common primary brain malignancy. Though literature has suggested the association of glioblastoma outcomes and socioeconomic status, there is limited evidence regarding the association of neighborhood-level socioeconomic deprivation on glioblastoma outcomes. The aim of this study was to assess the impact of neighborhood-level socioeconomic deprivation on glioblastoma survival. We retrospectively reviewed all adult glioblastoma patients seen at a single institution from 2008 to 2023. Neighborhood deprivation was assessed via Area Deprivation Index (ADI), with higher ADI indicating greater neighborhood socioeconomic disadvantage. Log-rank tests and multivariate cox regression was used to assess the effect of ADI and other socioeconomic variables while controlling for a priori selected clinical variables with known relevance to survival. In total, 1464 patients met inclusion criteria. The average age at diagnosis was 60 ± 14 years with a median overall survival of 13.8 months (IQR 13-14.8). The median ADI of the cohort was 66(IQR 46–84). Patients with high neighborhood disadvantage had worse overall survival compared to patients with those without (11.7 vs. 14.8 months, p =.001). In the multivariable model, patients with high neighborhood disadvantage had worse overall survival (HR 1.25, 95%CI 1.09–1.43). To account for changes in WHO guidelines, we implemented the model on patients diagnosed between 2017 and 2023 and findings were consistent (HR 1.26,95%CI 1.01–1.56). We report the first study demonstrating glioblastoma patients with higher neighborhood deprivation have worse survival after controlling for other socioeconomic and biomolecular markers. Neighborhood socioeconomic status may be a prognostic marker for glioblastoma survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Marnix E. Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
- Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, USA.
- O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
- Division of Neuro-Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
- Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, USA. jmarkert@uabmc.edu.
Förderung
- National Institute of Neurological Disorders and Stroke of the National Institutes of Health
Zitieren
APA
Sun, Y., Estevez-Ordonez, D., Atchley, T. J., Nabors, B., & M Markert, J. (2025). The association of neighborhood-level deprivation with glioblastoma outcomes: a single center cohort study. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-025-05002-3
Vancouver
Sun Y, Estevez-Ordonez D, Atchley TJ, Nabors B, M Markert J. The association of neighborhood-level deprivation with glioblastoma outcomes: a single center cohort study. Journal of Neuro-Oncology. 2025. doi:10.1007/s11060-025-05002-3
BibTeX
@article{Sun2025,
author = {Sun, Yifei and Estevez-Ordonez, Dagoberto and Atchley, Travis J and Nabors, Burt and M Markert, James},
title = {The association of neighborhood-level deprivation with glioblastoma outcomes: a single center cohort study},
journal = {Journal of Neuro-Oncology},
year = {2025},
doi = {10.1007/s11060-025-05002-3}
}
EUVIMED